Related Experiment Videos
Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory mIDH1 AML
Shira N Dinner1, Justin M Watts2, Jorge E Cortes3
1Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois, USA.
European Journal of Haematology
|August 14, 2026
Abstract
No abstract available in PubMed .